Strawberry Fields REIT, Inc. - Q3 2025 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. Strawberry Fields REIT, Inc. (the "Company") is a Maryland corporation operating as a Real Estate Investment Trust (REIT) in a UPREIT structure. The Company owns, acquires, and leases skilled nursing facilities and post-acute healthcare properties on a triple-net basis. As of September 30, 2025, the portfolio consisted of 132 properties (131 owned, 1 leased) with 15,542 licensed beds across 10 states. The Company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company.
Key Financial Metrics
| Metric | Q3 2025 (Three Months) | YTD 2025 (Nine Months) | YTD 2024 (Nine Months) |
|---|---|---|---|
| Rental Revenues | $39.7 million | $114.9 million | $86.6 million |
| Net Income (Total) | $8.9 million | $24.5 million | $19.9 million |
| Net Income Attributable to Common Stockholders | $2.0 million | $5.6 million | $2.6 million |
| Diluted EPS (Common) | $0.16 | $0.44 | $0.40 |
| Funds From Operations (FFO) | $20.7 million | $58.9 million | $44.6 million |
| Adjusted FFO | $18.1 million | $53.4 million | $41.6 million |
| Total Debt (Gross) | As of Sept 30, 2025: $779.4 million | ||
| Cash & Restricted Cash | |||
| Stockholders' Equity | As of Sept 30, 2025: $14.2 million | ||
| Total Equity (incl. NCI) |
Note: Non-controlling interest (NCI) represents approximately 77.3% of the Operating Partnership units. Net income attributable to common stockholders is significantly lower than total net income due to NCI allocations.
Material Changes vs. Prior Period
- Revenue Growth: Rental revenues increased 35% in Q3 2025 and 33% YTD 2025 compared to the prior year periods. This growth is primarily driven by the net acquisition of 27 properties and the commencement of a new master lease in Kentucky.
- Expense Increases: Total expenses rose 28% in Q3 and 26% YTD. Depreciation and amortization increased significantly (118% in Q3, 136% YTD) due to new property acquisitions and lease rights. Interest expense increased 51% in Q3 and 54% YTD, reflecting new commercial bank loans and bond issuances (Series A and B).
- Profitability: Net income attributable to common stockholders increased 114% in Q3 and 111% YTD, driven by higher rental income outpacing increased interest and depreciation costs.
- Balance Sheet: Total assets grew from $787.6 million (Dec 31, 2024) to $880.6 million (Sept 30, 2025). Real estate investments increased by $84.3 million. Total liabilities increased to $818.0 million, driven by new bond issuances and a $44.8 million note payable.
Guidance, Outlook, and Risks
Outlook and Capital Resources: The Company maintains a strategy of disciplined investment in healthcare real estate. As of September 30, 2025, the Company held $55.9 million in cash and restricted cash. It has capacity to issue additional bonds (Series A, C, and D) subject to covenants, and Series B bonds have no formal ceiling. The Company expects to meet long-term liquidity needs through operating cash flows, equity issuances, and debt offerings.
Recent Activity:
- Issued Series B Bonds (NIS 312 million / ~$89.5 million) in June 2025.
- Acquired 9 facilities in Missouri ($59 million) and individual properties in Texas, Oklahoma, and Kansas during the quarter.
- Sold one property in Michigan for $2.7 million, providing financing to the buyer.
- Subsequent Event: Entered an agreement on November 4, 2025, to acquire a 60-bed facility in Oklahoma for $3.0 million.
Risks and Contingencies:
- Legal Proceedings: The Company is involved in ongoing litigation with Joseph and Rosie Schwartz regarding property acquisitions from 2018-2019. The Company believes the claims are without merit and intends to defend vigorously. No material adverse effect is currently anticipated.
- Debt Covenants: The Company is subject to various financial covenants (e.g., Debt/EBITDA, DSCR, Minimum Equity). As of September 30, 2025, the Company was in compliance with all covenants. Breach could trigger interest rate increases or dividend restrictions.
- Interest Rate Risk: Approximately 20.8% of total debt ($161.8 million) is variable-rate (SOFR + margin). A 100 basis point increase in SOFR would decrease annual cash flow by approximately $1.6 million.
- Tenant Concentration: 67 of 142 tenants are related parties (controlled by CEO Moishe Gubin and Director Michael Blisko), concentrated in Indiana, Tennessee, and Illinois.
Investor Verification Checklist
- Verify the Non-Controlling Interest (NCI) allocation impact on net income attributable to common shareholders, as NCI holds ~77% of OP units.
- Review the Debt Maturity Wall: Significant balloon payments are due in 2026 (Series A, C, D bonds totaling ~$218 million) and 2027-2029.
- Assess the Related Party Transactions: Confirm the financial health of the 67 related-party tenants, which represent a significant portion of the portfolio.
- Monitor the Legal Proceedings status against the Schwartz plaintiffs to ensure no unexpected liabilities arise.
- Check Covenant Compliance ratios (Debt/EBITDA, DSCR) in future filings to ensure no breach triggers higher interest rates or dividend caps.
- Validate the Foreign Currency Impact on bond valuations (Series A, B, C, D are denominated in NIS), as exchange rate fluctuations affect reported debt balances.